Claire – Interview 24
Claire was diagnosed with CIN3 in 2008, aged 31. Her smear test results showed abnormalities but her colposcopies showed no abnormalities. She is thinking about participating in a clinical trial on photodynamic treatment for cervical conditions.
Claire always attended for cervical screening. She had had no symptoms so was very surprised when she was diagnosed with CIN3. Her smear test result showed abnormalities but her colposcopy showed no abnormalities. Two further smear tests were taken and both showed she had CIN3 but the colposcopies showed normal results. Claire felt unsure about having LLETZ treatment because more of her cervix could be removed than was necessary and affect future pregnancies. She might also have to be treated more than once and was concerned about being over-treated.
Claire had private health care insurance and asked to be tested for HPV. Test results showed that she had four strains of the virus and this increased her risk of having cervical cancer. Claire was particularly concerned about this because her aunt had died of cervical cancer.
After doing her own research, Claire discovered a clinical trail taking place in Belarus which focussed on using photodynamic therapy for cervical conditions. The trial would investigate whether photodynamic therapy could successfully treat cervical conditions, including cancer, without removing as much of the cervix as current treatments. At the time of interview, Claire was having regular colposcopies and thinking about participating in this trial.
Claire said that one of the most difficult aspects of having CIN3 was telling other people because it is caused by HPV. For her, dealing with other peoples; reactions was the worst part of the experience because HPV is sexually transmitted and some people associate it with promiscuity. Telling her parents and some of her colleagues was particularly difficult.
Claire would have liked more information from health professionals before going for colposcopy. She encouraged other women to attend for cervical screening andwas in favour ofthe HPV vaccine for younger girls.